Bath & Body Works, Inc. (NYSE:BBWI) Shares Purchased by GAMMA Investing LLC

GAMMA Investing LLC lifted its stake in Bath & Body Works, Inc. (NYSE:BBWI) by 78.7% in the fourth quarter, HoldingsChannel reports. The fund owned 4,434 shares of the company’s stock after purchasing an additional 1,953 shares during the quarter. GAMMA Investing LLC’s holdings in Bath & Body Works were worth $172,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. True Wealth Design LLC raised its holdings in Bath & Body Works by 5,270.0% during the third quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock worth $34,000 after purchasing an additional 1,054 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt boosted its stake in Bath & Body Works by 300.0% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after purchasing an additional 900 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new position in shares of Bath & Body Works during the 3rd quarter valued at $39,000. TD Private Client Wealth LLC raised its stake in shares of Bath & Body Works by 24.2% in the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after buying an additional 331 shares in the last quarter. Finally, Meeder Asset Management Inc. lifted its holdings in shares of Bath & Body Works by 480.3% in the third quarter. Meeder Asset Management Inc. now owns 1,735 shares of the company’s stock valued at $55,000 after buying an additional 1,436 shares during the period. 95.14% of the stock is currently owned by institutional investors.

Bath & Body Works Stock Up 0.2 %

Shares of Bath & Body Works stock opened at $36.94 on Thursday. Bath & Body Works, Inc. has a 12 month low of $26.20 and a 12 month high of $52.99. The stock has a market cap of $8.00 billion, a PE ratio of 9.01, a price-to-earnings-growth ratio of 1.43 and a beta of 1.82. The business has a fifty day simple moving average of $35.43 and a 200-day simple moving average of $33.78.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Monday, November 25th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.46 by $0.03. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The firm had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same period last year, the company posted $0.48 EPS. The business’s quarterly revenue was up 3.1% compared to the same quarter last year. Analysts expect that Bath & Body Works, Inc. will post 3.26 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 22nd were given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 2.17%. The ex-dividend date was Friday, November 22nd. Bath & Body Works’s payout ratio is presently 19.51%.

Analyst Upgrades and Downgrades

BBWI has been the topic of a number of research analyst reports. Telsey Advisory Group reaffirmed an “outperform” rating and set a $42.00 target price on shares of Bath & Body Works in a report on Monday, November 25th. Barclays lifted their price objective on shares of Bath & Body Works from $28.00 to $34.00 and gave the stock an “underweight” rating in a research note on Tuesday, November 26th. JPMorgan Chase & Co. boosted their target price on shares of Bath & Body Works from $35.00 to $39.00 and gave the stock a “neutral” rating in a report on Tuesday, November 26th. Piper Sandler raised their target price on shares of Bath & Body Works from $36.00 to $39.00 and gave the stock a “neutral” rating in a report on Monday. Finally, TD Cowen lifted their price target on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $42.69.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.